Michael K. Palmer

1.1k total citations
20 papers, 786 citations indexed

About

Michael K. Palmer is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Economics and Econometrics. According to data from OpenAlex, Michael K. Palmer has authored 20 papers receiving a total of 786 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 9 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Economics and Econometrics. Recurrent topics in Michael K. Palmer's work include Lipoproteins and Cardiovascular Health (12 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers) and Health Systems, Economic Evaluations, Quality of Life (8 papers). Michael K. Palmer is often cited by papers focused on Lipoproteins and Cardiovascular Health (12 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers) and Health Systems, Economic Evaluations, Quality of Life (8 papers). Michael K. Palmer collaborates with scholars based in United Kingdom, Australia and United States. Michael K. Palmer's co-authors include Peter P. Tóth, Philip J. Barter, Björn W. Karlson, Pia Lundman, Stephen J. Nicholls, Derek Crowther, Charles B. Pratt, Nicholas Thatcher, Evan A. Stein and Olov Wiklund and has published in prestigious journals such as Circulation, Cancer and The American Journal of Cardiology.

In The Last Decade

Michael K. Palmer

19 papers receiving 746 citations

Peers

Countries citing papers authored by Michael K. Palmer

Since Specialization

Citations

This map shows the geographic impact of Michael K. Palmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael K. Palmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael K. Palmer more than expected).

Fields of papers citing papers by Michael K. Palmer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael K. Palmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael K. Palmer. The network helps show where Michael K. Palmer may publish in the future.

Co-authorship network of co-authors of Michael K. Palmer

This figure shows the co-authorship network connecting the top 25 collaborators of Michael K. Palmer. A scholar is included among the top collaborators of Michael K. Palmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael K. Palmer. Michael K. Palmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Abstract 14675: Rising Prevalence of Obesity in the Us: National Health and Nutrition Examination Survey (NHANES) 2003-2018 2020 ·Circulation ·Michael K. Palmer, Peter P. Tóth	1
2	Trends in Lipids, Obesity, Metabolic Syndrome, and Diabetes Mellitus in the United States: An NHANES Analysis (2003‐2004 to 2013‐2014) 2019 ·Obesity ·Michael K. Palmer, Peter P. Tóth	107
3	Comparing a novel equation for calculating low-density lipoprotein cholesterol with the Friedewald equation: A VOYAGER analysis 2018 ·Clinical Biochemistry ·Michael K. Palmer, Philip J. Barter, Pia Lundman, Stephen J. Nicholls, Peter P. Tóth, Björn W. Karlson	35
4	Modeling Statin-Induced Reductions of Cardiovascular Events in Primary Prevention: A VOYAGER Meta-Analysis 2018 ·Cardiology ·Björn W. Karlson, Stephen J. Nicholls, Pia Lundman, Philip J. Barter, Michael K. Palmer	4
5	Effects of age, gender and statin dose on lipid levels: Results from the VOYAGER meta-analysis database 2017 ·Atherosclerosis ·Björn W. Karlson, Michael K. Palmer, Stephen J. Nicholls, Philip J. Barter, Pia Lundman	27
6	A VOYAGER Meta-Analysis of the Impact of Statin Therapy on Low-Density Lipoprotein Cholesterol and Triglyceride Levels in Patients With Hypertriglyceridemia 2016 ·The American Journal of Cardiology ·Björn W. Karlson, Michael K. Palmer, Stephen J. Nicholls, Pia Lundman, Philip J. Barter	66
7	Variability of low-density lipoprotein cholesterol response with different doses of atorvastatin, rosuvastatin, and simvastatin: results from VOYAGER 2016 ·European Heart Journal - Cardiovascular Pharmacotherapy ·Björn W. Karlson, Olov Wiklund, Michael K. Palmer, Stephen J. Nicholls, Pia Lundman, Philip J. Barter	91
8	Treatment patterns and LDL-C goal attainment in patients with diabetes: Temporal trends analysis from National Health and Nutrition Examination Survey† 2016 ·Journal of clinical lipidology ·Peter P. Tóth, Karin Henriksson, Michael K. Palmer	1
9	Metabolic Syndrome And Low-Density Lipoprotein Cholesterol Goal Attainment In The National Health And Nutrition Examination Survey (2003–2012) † 2016 ·Journal of clinical lipidology ·Peter P. Tóth, Karin Henriksson, Michael K. Palmer	2
10	To what extent do high-intensity statins reduce low-density lipoprotein cholesterol in each of the four statin benefit groups identified by the 2013 American College of Cardiology/American Heart Association guidelines? A VOYAGER meta-analysis 2015 ·Atherosclerosis ·Björn W. Karlson, Michael K. Palmer, Stephen J. Nicholls, Pia Lundman, Philip J. Barter	14
11	Doses of rosuvastatin, atorvastatin and simvastatin that induce equal reductions in LDL-C and non-HDL-C: Results from the VOYAGER meta-analysis 2015 ·European Journal of Preventive Cardiology ·Björn W. Karlson, Michael K. Palmer, Stephen J. Nicholls, Pia Lundman, Philip J. Barter	46
12	Achievement of combined goals of low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol with three different statins: Results from VOYAGER 2014 ·Adelaide Research & Scholarship (AR&S) (University of Adelaide) ·Björn W. Karlson, Peter P. Tóth, Michael K. Palmer, Philip J. Barter, Stephen J. Nicholls	0
13	A dose-titration and comparative study of rosuvastatin and atorvastatin in patients with homozygous familial hypercholesterolaemia 2007 ·Atherosclerosis ·A. David Marais, Frederick J. Raal, Evan A. Stein, Daniel J. Rader, James W. Blasetto, Michael K. Palmer, Wim Wilpshaar	69
14	Efficacy and safety of rosuvastatin 40mg versus atorvastatin 80 mg in high-risk patients with hypercholesterolemia: Results of the POLARIS study 2007 ·Atherosclerosis ·Lawrence A. Leiter, Robert S. Rosenson, Evan A. Stein, John Reckless, Karl-Ludwig Schulte, (unknown), Paul Miller, Michael K. Palmer, (unknown)	51
15	Comparison of the efficacy and safety of rosuvastatin 10 mg and atorvastatin 20 mg in high-risk patients with hypercholesterolemia – Prospective study to evaluate the Use of Low doses of the Statins Atorvastatin and Rosuvastatin (PULSAR) 2006 ·Trials ·Michael Clearfield, John Amerena, Jean‐Pierre Bassand, (unknown), Sam S. Miller, (unknown), Michael K. Palmer, Brian Bryzinski	68
16	Costs Incurred by Patients Undergoing Advanced Colorectal Cancer Therapy 2000 ·PharmacoEconomics ·Mark Sculpher, Michael K. Palmer, Anne Heyes	35
17	The prognostic significance of mediastinal bulk in patients with stage IA-IVB Hodgkin's disease: A report from the Manchester Lymphoma Group 1985 ·Clinical Radiology ·Heather Anderson, (unknown), (unknown), D.P. Deakin, Michael K. Palmer, Ian Todd, Derek Crowther	28
18	Prognostic significance of pretreatment serum β2-microglobulin levels in multiple myeloma 1983 ·European Journal of Cancer and Clinical Oncology ·J.H. Scarffe, Heather Anderson, Michael K. Palmer, Derek Crowther	29
19	Malignant melanoma in children and adolescents 1981 ·Cancer ·Charles B. Pratt, Michael K. Palmer, Nicholas Thatcher, Derek Crowther	76
20	The prognostic significance of radiological and symptomatic bone involvement in childhood acute lymphoblastic leukaemia 1979 ·Medical and Pediatric Oncology ·Ian Hann, Subhash Gupta, Michael K. Palmer, P. H. Morris‐Jones	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact